Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

BAP1-Mutated Clear Cell Renal Cell Carcinoma.

American journal of clinical pathology - 26 Apr 2021

Gallan Alexander J, Parilla Megan, Segal Jeremy, Ritterhouse Lauren, Antic Tatjana

Abstract excerpt

OBJECTIVES: While aberrations in the VHL gene and chromosome 3p resulting in clear cell renal cell carcinoma (CCRCC) are well established, we know that additional mutations in chromatin remodeling genes PBRM1, SETD2, and BRCA1-associated protein 1 (BAP1) contribute to pathogenesis in some cases. Given the known aggressive clinical behavior of BAP1-mutated CCRCC, we sought to define the pathologic phenotype of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Renal Cell
Share to Gene Expression Regulation, Neoplastic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Kidney Neoplasms

Share to Nuclear Proteins

Share to Prognosis

Share to Transcription Factors

Share to Tumor Suppressor Proteins

Share to Ubiquitin Thiolesterase

Source

Identifiers

PMID: 33210135
DOI: 10.1093/ajcp/aqaa176

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

BAP1-Mutated Clear Cell Renal Cell Carcinoma.PMID 33210135Read ↗

BAP1, PBRM1 and SETD2 in clear-cell renal cell carcinoma: molecular diagnostics and possible targets for personalized therapies.Semantic proximity Read ↗

[Clinicopathological features of BAP1 mutated clear cell renal cell carcinoma].Semantic proximity Read ↗

Clinical and pathologic impact of select chromatin-modulating tumor suppressors in clear cell renal cell carcinoma.Semantic proximity Read ↗

The expanding role of BAP1 in clear cell renal cell carcinoma.Semantic proximity Read ↗

Morphological characteristics of SETD2-mutated locally advanced clear cell renal cell carcinoma: Comparison with BAP1-mutated clear cell renal cell carcinoma.Semantic proximity Read ↗

Clinical and pathological impact of VHL, PBRM1, BAP1, SETD2, KDM6A, and JARID1c in clear cell renal cell carcinomaSemantic proximity Read ↗

BAP1 immunohistochemistry predicts outcomes in a multi-institutional cohort with clear cell renal cell carcinoma.Semantic proximity Read ↗

Exploration of Morphological Features of Clear Cell Renal Cell Carcinoma With PBRM1, SETD2, BAP1, or KDM5C Mutations.Semantic proximity Read ↗

Expression and Mutation Patterns of PBRM1, BAP1 and SETD2 Mirror Specific Evolutionary Subtypes in Clear Cell Renal Cell CarcinomaSemantic proximity Read ↗

Molecular genetics of clear-cell renal cell carcinoma.Semantic proximity Read ↗

Loss of PBRM1 expression is associated with renal cell carcinoma progression.Semantic proximity Read ↗

Epigenome Aberrations: Emerging Driving Factors of the Clear Cell Renal Cell Carcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.